您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

In Vivo Star Anti-Mouse CD154 (CD40L) Antibody

In Vivo Star Anti-Mouse CD154 (CD40L) Antibody

英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse CD154 (CD40L) Antibody(克隆 MR1) 为Armenian Hamster IgG 抗体,靶向 CD154(别名 CD40L 等)。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 512001 更新 2026-11-12
参考价格区间
¥1,085
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse CD154 (CD40L) Antibody(克隆 MR1) 为Armenian Hamster IgG 抗体,靶向 CD154(别名 CD40L 等)。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

511901 | 1 mg | ¥1,085

511902 | 5 mg | ¥2,712

511903 | 25 mg | ¥7,458

512001 | 1 mg | ¥1,085

512002 | 5 mg | ¥2,712

512003 | 25 mg | ¥7,458

Product Details

Application|ELISA, WB, Flow cytometry, IHC, ICC, animal model study

Product Description|In vivo Grade Recombinant Anti-mouse CD40L (CD154) Monoclonal Antibody

Regulatory Status|RUO

Endotoxin

Storage Conditions|4ºC

Recommended Usage|This product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.

See All Formats|Clone MR1

Background Information

CD154, also known as CD40 ligand (CD40L) or TNFSF5, is a key immunoregulatory molecule that plays a central role in communication between T cells and antigen-presenting cells. It is most prominently expressed on activated CD4+ T helper cells, but can also be found on activated CD8+ T cells, platelets, B cells, and other immune cell types under certain conditions. CD154 is essential for coordinating adaptive immune responses, particularly those involving B cell activation and antibody production.

Structurally, CD154 is a type II transmembrane glycoprotein and a member of the tumor necrosis factor (TNF) superfamily. It consists of a short N-terminal cytoplasmic domain, a single transmembrane region, and a C-terminal extracellular domain that forms homotrimers, a characteristic feature of TNF family ligands. Trimerization of CD154 is required for effective binding and activation of its receptor, enabling efficient signal transduction in CD40-expressing cells.

The principal ligand for CD154 is CD40, a receptor expressed on B cells, dendritic cells, macrophages, monocytes, and various non-hematopoietic cells. Engagement of CD40 by CD154 delivers a potent activation signal to antigen-presenting cells. In B cells, this interaction is required for immunoglobulin class switching, germinal center formation, somatic hypermutation, and the development of memory B cells and long-lived plasma cells. In dendritic cells and macrophages, CD154–CD40 signaling enhances antigen presentation, cytokine production, and the ability to prime naïve T cells.

Defects in CD154 expression or function have profound clinical consequences. Genetic deficiency of CD154 causes X-linked hyper-IgM syndrome, characterized by impaired immunoglobulin class switching, recurrent infections, and defective humoral immunity. Conversely, excessive or prolonged CD154 expression contributes to pathological inflammation in autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis, as well as in transplant rejection and atherosclerosis. CD154 expressed on platelets has also been implicated in thromboinflammatory processes.

Therapeutically, the CD154–CD40 pathway has attracted significant interest. Blocking CD154 or CD40 can dampen pathogenic immune activation and is being explored as a strategy for treating autoimmune disease and preventing transplant rejection. However, early anti-CD154 therapies were associated with thrombotic complications due to platelet expression of CD154, prompting the development of safer approaches targeting CD40 instead. Conversely, agonistic strategies that enhance CD154–CD40 signaling are being investigated to boost immune responses in cancer immunotherapy and vaccine development. Together, these approaches highlight CD154’s critical role in immune regulation and therapeutic intervention.

Data Sheets

Cat # Size Price Quantity 5120011 mg Add to Cart5120025 mg Add to Cart51200325 mg Add to Cart

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格1 mg
CloneMR1
Host SpeciesCHO cells
ReactivityMouse
FormatLiquid
Target NameCD154, CD40L, gp39, TRAP, T-BAM, TNFSF5, CD40 Ligand
Product DescriptionIn vivo Grade Recombinant Anti-mouse CD40L (CD154) Monoclonal Antibody
IsotypeArmenian Hamster IgG
Antibody TypeRecombinant
Regulatory StatusRUO
Purity>95% by reducing SDS-PAGE
Storage Conditions4ºC
GradeIn vivo
Recommended UsageThis product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.
RRIDAB_3739394
目录价¥1,085

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). In Vivo Star Anti-Mouse CD154 (CD40L) Antibody(512001)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd154-cd40l-antibody-512001.html.
TeleVM. (2026, November 12). In Vivo Star Anti-Mouse CD154 (CD40L) Antibody(512001). 产品目录. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd154-cd40l-antibody-512001.html
@misc{biocsp_item_in_vivo_star_anti_mouse_cd154_cd40l_antibody_512001,
  title        = {In Vivo Star Anti-Mouse CD154 (CD40L) Antibody(512001)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-cd154-cd40l-antibody-512001.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

In Vivo Star Anti-Mouse CD154 (CD40L) Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。